News | January 18, 2023
Cipla launches Cippoint
Point-of-Care solution to facilitate clinicians in quick and effective decision making
Point-of-Care solution to facilitate clinicians in quick and effective decision making
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
It provides Covid-19 detection and Omicron surveillance in less than two hours
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)